<DOC>
	<DOC>NCT00364624</DOC>
	<brief_summary>Patients with newly diagnosed lung cancer may have hypofunction of the adrenal cortex either from tumour metastasis or other mechanisms. Since lung cancer patient may have to undergo stressful investigation and treatments, undetected hypofunction of the adrenal cortex may be hazardous. Knowledge of the size of the problem may help determine whether routine check is warranted.</brief_summary>
	<brief_title>Adrenal Function in Patients With Newly Diagnosed Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Adrenal Insufficiency</mesh_term>
	<mesh_term>Epinephrine</mesh_term>
	<mesh_term>Racepinephrine</mesh_term>
	<mesh_term>Epinephryl borate</mesh_term>
	<criteria>Histologically proven primary lung cancer Newly diagnosed No specific treatment given No active infection in the previous week No general anesthesia in the previous week Known adrenal disease Receiving exogenous systemic corticosteroids Concomitant illness known to affect adrenal function. e.g. active TB</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>lung cancer</keyword>
	<keyword>adrenal insufficiency</keyword>
</DOC>